Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyu-Pyo Kim

Showing results (41-50 of 217) with videos related to

Pageof 22
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 5, 2013
High throughput molecular profiling reveals differential mutation patterns in intrahepatic cholangiocarcinomas arising in chronic advanced liver diseasesSejin Jang, Sung-Min Chun, Seoung-Mo Hong, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2014
EGFR-TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutationDong-Hoe Koo, Kyu-pyo Kim, Chang-Min Choi, et al.
Investigational New Drugs|December 12, 2018
Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysisJunho Kang, Changhoon Yoo, Hee-Sang Hwang, et al.
Computer Methods and Programs in Biomedicine|May 20, 2022
RIDAB: Electronic medical record-integrated real world data platform for predicting and summarizing interactions in biomedical research from heterogeneous data resourcesYunha Kim, Imjin Ahn, Ha Na Cho, et al.
Cancer Research and Treatment|April 29, 2016
Use of a High-Throughput Genotyping Platform (OncoMap) for <i>RAS</i> Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal CancerDalyong Kim, Yong Sang Hong, Jeong Eun Kim, et al.
Frontiers in Oncology|April 6, 2026
Prognostic implications of body composition changes in patients with non-metastatic pancreatic adenocarcinoma treated with mFOLFIRINOXJong Hyuk Lee, Yousun Ko, Seongwon Na, et al.
Anticancer Research|August 28, 2025
A Phase II Trial of Pemetrexed Plus Oxaliplatin in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin-based ChemotherapyJwa Hoon Kim, Changhoon Yoo, Hyehyun Jeong, et al.
Medicine|September 29, 2020
Evaluating waiting time with real-world health information in a high-volume cancer centerKyu-Pyo Kim, Yu Rang Park, Jung Bok Lee, et al.
European Radiology|August 20, 2020
Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancerJi Hun Kang, Seung Soo Lee, Jin Hee Kim, et al.
JCO Clinical Cancer Informatics|December 2, 2025
Predicting Chemotherapy Response in Patients With Advanced or Metastatic Pancreatic Cancer Using Machine LearningJamin Koo, Gyucheol Choi, Jaekyung Cheon, et al.
Pageof 22

Showing results (41-50 of 217) with videos related to

Sort By:
Pageof 22
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 5, 2013
High throughput molecular profiling reveals differential mutation patterns in intrahepatic cholangiocarcinomas arising in chronic advanced liver diseasesSejin Jang, Sung-Min Chun, Seoung-Mo Hong, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2014
EGFR-TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutationDong-Hoe Koo, Kyu-pyo Kim, Chang-Min Choi, et al.
Investigational New Drugs|December 12, 2018
Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysisJunho Kang, Changhoon Yoo, Hee-Sang Hwang, et al.
Computer Methods and Programs in Biomedicine|May 20, 2022
RIDAB: Electronic medical record-integrated real world data platform for predicting and summarizing interactions in biomedical research from heterogeneous data resourcesYunha Kim, Imjin Ahn, Ha Na Cho, et al.
Cancer Research and Treatment|April 29, 2016
Use of a High-Throughput Genotyping Platform (OncoMap) for <i>RAS</i> Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal CancerDalyong Kim, Yong Sang Hong, Jeong Eun Kim, et al.
Frontiers in Oncology|April 6, 2026
Prognostic implications of body composition changes in patients with non-metastatic pancreatic adenocarcinoma treated with mFOLFIRINOXJong Hyuk Lee, Yousun Ko, Seongwon Na, et al.
Anticancer Research|August 28, 2025
A Phase II Trial of Pemetrexed Plus Oxaliplatin in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin-based ChemotherapyJwa Hoon Kim, Changhoon Yoo, Hyehyun Jeong, et al.
Medicine|September 29, 2020
Evaluating waiting time with real-world health information in a high-volume cancer centerKyu-Pyo Kim, Yu Rang Park, Jung Bok Lee, et al.
European Radiology|August 20, 2020
Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancerJi Hun Kang, Seung Soo Lee, Jin Hee Kim, et al.
JCO Clinical Cancer Informatics|December 2, 2025
Predicting Chemotherapy Response in Patients With Advanced or Metastatic Pancreatic Cancer Using Machine LearningJamin Koo, Gyucheol Choi, Jaekyung Cheon, et al.
Pageof 22